Ipratropium Nasal — $0 with Membership
Ipratropium Nasal has an active canonical formulary match. No-additional-cost pricing is subject to its listed supply, quantity, fill, and fulfillment limits.
Ipratropium Nasal Pricing
| Pricing type | Price |
|---|---|
| TheDrugClub | $0 with membership |
| Typical Retail | $57.00 |
Free with membership subject to the listed formulary limits.
About Ipratropium Nasal
Ipratropium Nasal is a prescription medication. Ask your doctor if Ipratropium Nasal is right for you.
Other strengths and forms of Ipratropium
- Ipratropium
- Ipratropium Bromide
- Ipratropium 17 mcg inhaler
- Ipratropium Bromide 0.0 6% 15mL 0.06% (42mcg/Spray ) Nasal Spray
Combination products containing Ipratropium
How to Check Ipratropium Nasal Pricing
- Join TheDrugClub for $19.95/month
- Receive your member card by email
- Present your card at a participating pharmacy
- Check active-formulary eligibility or available membership pricing
Ipratropium Nasal at Participating Pharmacies
- CVS Pharmacy
- Walgreens
- Walmart Pharmacy
- Rite Aid
- Kroger Pharmacy
- Costco Pharmacy
- Albertsons
- Safeway
- Publix Pharmacy
- H-E-B Pharmacy
Pharmacy participation and fulfillment options vary. Present your membership card and confirm current pricing before filling.
Other medications in Allergy & Immunology
What Ipratropium Nasal is approved for (FDA label)
Ipratropium bromide nasal solution, 0.06% is indicated for the symptomatic relief of rhinorrhea associated with the common cold or seasonal allergic rhinitis for adults and children age 5 years and older. Ipratropium bromide 0.06% does not relieve nasal congestion or sneezing associated with the common cold or seasonal allergic rhinitis. The safety and effectiveness of the use of ipratropium bromide 0.06% beyond four days in patients with the common cold or beyond three weeks in patients with seasonal allergic rhinitis has not been established.
Source: Read the full FDA label on DailyMed. Label effective date: July 14, 2026.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.
Adverse reactions for Ipratropium Nasal (FDA label)
Adverse reaction information on ipratropium bromide 0.06% in patients with the common cold was derived from two multicenter, vehicle-controlled clinical trials involving 1,276 patients (195 patients on ipratropium bromide 0.03%, 352 patients on ipratropium bromide, 0.06%, 189 patients on ipratropium bromide 0.12%, 351 patients on vehicle and 189 patients receiving no treatment). Table 1 shows adverse events reported for patients who received ipratropium bromide 0.06% at the recommended dose of 84 mcg per nostril, or vehicle, administered three or four times daily, where the incidence is 1% or greater in the ipratropium bromide group and higher in the ipratropium bromide group than in the vehicle group.
Source: FDA prescribing information (DailyMed). Set ID: 7e8fdd92-1e55-47e2-aa85-e48cfebbb8d7. SPL document ID: 568fa03b-f12a-a131-e063-6294a90a66b8. Label effective date: July 14, 2026. Read the full label.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.
Contraindications for Ipratropium Nasal (FDA label)
Ipratropium bromide nasal solution, 0.06% is contraindicated in patients with a history of hypersensitivity to atropine or its derivatives, or to any of the other ingredients.
Source: FDA prescribing information (DailyMed). Set ID: 7e8fdd92-1e55-47e2-aa85-e48cfebbb8d7. SPL document ID: 568fa03b-f12a-a131-e063-6294a90a66b8. Label effective date: July 14, 2026. Read the full label.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.